Anonymous ID: 270a77 Jan. 6, 2024, 9:53 a.m. No.20194875   🗄️.is 🔗kun   >>4984 >>5002 >>5080 >>5183 >>5385 >>5488 >>5537 >>5576

Shocking spike in cancer drug sales, across all cancers but most notably Brain cancer

 

🚨🚨🚨

Holy Moly!

I just received Cancer Sales Data for 2023 from industry sources.

Shocking spike in cancer drug sales, across all cancers but most notably Brain cancer. Look at Temodal sales below!

 

Temodal(generic name temozolomide) is an oral chemotherapy drug that is widely recognized as the most frequently used medication for treating certain types of brain cancer.

 

The drug is more than 20 years in the market and suddenly tripled in a span of two years from 2020 to 2022. I've never seen a 20 year old generic drug spike like this in my pharma career!

 

I wonder whats happening!

https://twitter.com/_aussie17/status/1743633057356386681

 

 

Kevin McKernan:

“There is no increase in cancer! It’s all anecdotal”.

 

Sales numbers don’t lie.

https://twitter.com/Kevin_McKernan/status/1743651601858867384

 

 

Ed Dowd:

Makes sense to me.

https://twitter.com/DowdEdward/status/1743681587324281313